US Patent Issued to Scarcell Technologies on March 25 for "Mammalian cell population and medicaments for cell therapies in humans and improved cell cultivation methods" (French Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,579, issued on March 25, was assigned to Scarcell Technologies (Paris).

"Mammalian cell population and medicaments for cell therapies in humans and improved cell cultivation methods" was invented by Antoine Lafont (Paris) and Mathieu Castela (Clamart, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions of matter, including cell populations and medicaments, are provided that are derived from human gingival fibroblasts and have cell phenotypes that occur in proportions not found in natural gum tissue, but rather, are preferentially are selected to express proteins favoring angiogenesis and anti-inflammatory effects, while reducing cell...